EGR3 and estrone are involved in the tamoxifen resistance and progression of breast cancer

Yu Xie(Nankai University), Yue Wang(Tianjin Nankai Hospital)
Journal of Cancer Research and Clinical Oncology
November 24, 2023
Cited by 12


Related Papers